SHZ · Financial Statements

Honz Pharmaceutical Co., Ltd. (300086.SZ) Financial Statements

$4.82 SHZ: 300086.SZ Market Cap $3.05B

Full income statement, balance sheet, and cash flow statement for Honz Pharmaceutical Co., Ltd. (300086.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-53.94
FCF Yield—
Quick Ratio0.10
Interest Coverage—
Return 1Y-30.14%
Return 3Y-20.20%
Return 5Y0.21%

Honz Pharmaceutical Co., Ltd. (300086.SZ) financials — frequently asked questions

What is 300086.SZ EV/EBITDA?

Honz Pharmaceutical Co., Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is -53.94. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
300086.SZ Overview 300086.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.